EMEA-001087-PIP02-12-M03 - paediatric investigation plan

Budesonide

Key facts

• Active Substance:
  Budesonide
• Therapeutic area:
  Pneumology-allergology
• Decision number:
  P/0014/2017
• PIP number:
  EMEA-001087-PIP02-12-M03
• Pharmaceutical form(s):
  Nebuliser suspension
• Condition(s) / indication(s):
  Treatment of asthma
• Route(s) of administration:
  Inhalation use
• Decision type:
  PM: decision on the application for modification of an agreed PIP
• Decision date:
  31/01/2017

Decision

P/0014/2017: EMA decision of 31 January 2017 on the acceptance of a modification of an agreed paediatric investigation plan for budesonide (EMEA- 001087-PIP02-12-M03)

AdoptedReference Number: EMA/38337/2017